Strax

Autospela

Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

6 Visningar • 07/30/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela